5 stories mentioning LMATUpdated 8d ago
Every FINWIRES story that references LMAT, newest first.
LeMaitre Vascular (LMAT) has an average rating of overweight and mean price target of $116.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
LeMaitre Vascular (LMAT) has an average rating of overweight and mean price target of $116.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Trent G Kamke, Senior Vice President, Operations, on May 08, 2026, sold 2,928 shares in Lemaitre Vascular (LMAT) for $313,287. Following the Form 4 filing with the SEC, Kamke has control over a total of 3,749 common shares of the company, with 3,749 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1158895/000119312526217113/xslF345X05/ownership.xml
Lawrence J Jasinski, Director, on May 07, 2026, sold 3,943 shares in Lemaitre Vascular (LMAT) for $433,730. Following the Form 4 filing with the SEC, Jasinski has control over a total of 4,714 common shares of the company, with 4,714 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1158895/000119312526217096/xslF345X05/ownership.xml
LeMaitre Vascular (LMAT) has an average rating of overweight and mean price target of $117, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $106.04, Change: $-5.96, Percent Change: -5.32%
